Project Details
Description
Development of a novel personalized medicine platform using apheretically isolated circulating tumor cells to assess drug responsiveness in prostate cancer
Status | Finished |
---|---|
Effective start/end date | 6/1/22 → 5/31/23 |
Funding
- ASTRIN BIOSCIENCES, INC
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.